08.09.2020

Blueberries Medical to Webcast Live at VirtualInvestorConferences.com on September 10th

TORONTO, Sept. 08, 2020 (GLOBE NEWSWIRE) -- Blueberries Medical Corp.

10.07.2020

BBM - Information Circular 2020

BLUBERRIES MEDICAL CORP.
Notice of Annual General and Special Meeting of Shareholders
June 24, 2020
Management Information Circular

See more

10.07.2020

Sedar Return Card

Under securities regulations, a reporting issuer must send annually a form to holders to request the Interim Financial Statements
and MD&A and/or the Annual Financial Statements and MD&A. If you would like to receive the report(s) by mail, please make
your selection and return to the address as noted or register online at www.computershare.com/mailinglist.

09.06.2020

Blueberries Announces Strategic Partnership with medcann

TORONTO, June 08, 2020 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce  that its wholly-owned subsidiary Blueberries SAS entered into a collaboration agreement (the "Partnership") with Medicamentos de Cannabis SAS (“medcann”), to develop, and produce Tetrahydrocannabinol (“THC”) cannabis extracts for the international market.

02.06.2020

Blueberries Commences Commercial Sales of Proprietary Cultivars to Local Partners

Toronto, Ontario (June 2, 2020) – Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce that it has officially commenced sales of its proprietary cultivars approved by the Colombian Institute of Agriculture (“ICA”). 

11.05.2020

Blueberries Medical to export cannabis oil from Colombia into the US market in 3Q of this year

Blueberries Medical Corp. (CSE: BBM) (OTCQB: BBRRF) CFO Ian Atacan tells Proactive the Toronto-headquartered medical cannabis producer with operations in Colombia will be entering the US market by way of its joint venture with Colombia-based QualCann SAS.

05.05.2020

Blueberries Medical Announces Joint Venture with QualCann SAS to Export to the US Market

TORONTO, May 05, 2020 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce that the Company has entered into a Joint Venture (the “JV”) with QualCann SAS (“QualCann”), an arm’s length third party, to produce extract oil to be commercialized in the United States of America (“US”) market.

16.12.2019

Blueberries Medical Appoints Co-Founder Camilo Villalba as CEO, Exports Expected to Commence in First Half of 2020

TORONTO, Dec. 16, 2019 (GLOBE NEWSWIRE) -- Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the "Company" or "Blueberries"), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce that the Board of Directors has appointed Mr. Camilo Villalba as Chief Executive Officer of the Company. Mr.

Subscribe to Media